208 related articles for article (PubMed ID: 28929550)
1. Characteristics and clinical outcomes of pleomorphic lobular carcinoma in situ of the breast.
Fasola CE; Chen JJ; Jensen KC; Allison KH; Horst KC
Breast J; 2018 Jan; 24(1):66-69. PubMed ID: 28929550
[TBL] [Abstract][Full Text] [Related]
2. Treatment Outcomes for Pleomorphic Lobular Carcinoma In Situ of the Breast.
Desai AA; Jimenez RE; Hoskin TL; Day CN; Boughey JC; Hieken TJ
Ann Surg Oncol; 2018 Oct; 25(10):3064-3068. PubMed ID: 29947004
[TBL] [Abstract][Full Text] [Related]
3. Pleomorphic Lobular Carcinoma In Situ: Imaging Features, Upgrade Rate, and Clinical Outcomes.
Savage JL; Jeffries DO; Noroozian M; Sabel MS; Jorns JM; Helvie MA
AJR Am J Roentgenol; 2018 Aug; 211(2):462-467. PubMed ID: 29894223
[TBL] [Abstract][Full Text] [Related]
4. Pleomorphic lobular carcinoma in situ of the breast: a single institution experience with clinical follow-up and centralized pathology review.
De Brot M; Koslow Mautner S; Muhsen S; Andrade VP; Mamtani A; Murray M; Giri D; Sakr RA; Brogi E; King TA
Breast Cancer Res Treat; 2017 Sep; 165(2):411-420. PubMed ID: 28612228
[TBL] [Abstract][Full Text] [Related]
5. When pathological and radiological correlation is achieved, excision of fibroadenoma with lobular neoplasia on core biopsy is not warranted.
Fives C; O'Neill CJ; Murphy R; Corrigan MA; O'Sullivan MJ; Feeley L; Bennett MW; O'Connell F; Browne TJ
Breast; 2016 Dec; 30():125-129. PubMed ID: 27718416
[TBL] [Abstract][Full Text] [Related]
6. Pleomorphic LCIS what do we know? A UK multicenter audit of pleomorphic lobular carcinoma in situ.
Masannat YA; Husain E; Roylance R; Heys SD; Carder PJ; Ali H; Maurice Y; Pinder SE; Sawyer E; Shaaban AM
Breast; 2018 Apr; 38():120-124. PubMed ID: 29310036
[TBL] [Abstract][Full Text] [Related]
7. Pleomorphic and Florid Lobular Carcinoma In Situ Variants of the Breast: A Clinicopathologic Study of 85 Cases With and Without Invasive Carcinoma From a Single Academic Center.
Shamir ER; Chen YY; Chu T; Pekmezci M; Rabban JT; Krings G
Am J Surg Pathol; 2019 Mar; 43(3):399-408. PubMed ID: 30489319
[TBL] [Abstract][Full Text] [Related]
8. Evaluating agreement, histological features, and relevance of separating pleomorphic and florid lobular carcinoma in situ subtypes.
Singh K; Paquette C; Kalife ET; Wang Y; Mangray S; Quddus MR; Steinhoff MM
Hum Pathol; 2018 Aug; 78():163-170. PubMed ID: 29753007
[TBL] [Abstract][Full Text] [Related]
9. Pleomorphic Lobular Carcinoma In Situ: Radiologic-Pathologic Features and Clinical Management.
Flanagan MR; Rendi MH; Calhoun KE; Anderson BO; Javid SH
Ann Surg Oncol; 2015 Dec; 22(13):4263-9. PubMed ID: 25893410
[TBL] [Abstract][Full Text] [Related]
10. Pleomorphic Lobular Carcinoma in Situ Diagnosed by Breast Core Biopsy: Clinicopathologic Features and Correlation With Subsequent Excision.
Guo T; Wang Y; Shapiro N; Fineberg S
Clin Breast Cancer; 2018 Aug; 18(4):e449-e454. PubMed ID: 29102711
[TBL] [Abstract][Full Text] [Related]
11. Morphologic subtypes of lobular carcinoma in situ diagnosed on core needle biopsy: clinicopathologic features and findings at follow-up excision.
Kuba MG; Murray MP; Coffey K; Calle C; Morrow M; Brogi E
Mod Pathol; 2021 Aug; 34(8):1495-1506. PubMed ID: 33824462
[TBL] [Abstract][Full Text] [Related]
12. The significance of lobular carcinoma in situ and atypical lobular hyperplasia of the breast.
Lewis JL; Lee DY; Tartter PI
Ann Surg Oncol; 2012 Dec; 19(13):4124-8. PubMed ID: 22847126
[TBL] [Abstract][Full Text] [Related]
13. Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies.
Renshaw AA; Gould EW
Pathology; 2016 Jan; 48(1):25-9. PubMed ID: 27020205
[TBL] [Abstract][Full Text] [Related]
14. Upgrade Rates of Variant Lobular Carcinoma In Situ Compared to Classic Lobular Carcinoma In Situ Diagnosed in Core Needle Biopsies: A 10-Year Single Institution Retrospective Study.
Harinath L; Villatoro TM; Clark BZ; Fine JL; Yu J; Carter GJ; Diego E; McAuliffe PF; Mai P; Lu A; Zuley M; Berg WA; Bhargava R
Mod Pathol; 2024 Apr; 37(4):100462. PubMed ID: 38428736
[TBL] [Abstract][Full Text] [Related]
15. The Pathologic Finding of Combined Lobular Carcinoma
Jean-Louis CJ; Masdon J; Smith B; Battles O; Dale P
Am Surg; 2017 May; 83(5):482-485. PubMed ID: 28541858
[TBL] [Abstract][Full Text] [Related]
16. Pre-operative management of Pleomorphic and florid lobular carcinoma in situ of the breast: Report of a large multi-institutional series and review of the literature.
Foschini MP; Miglio R; Fiore R; Baldovini C; Castellano I; Callagy G; Bianchi S; Kaya H; Amendoeira I; Querzoli P; Poli F; Scatena C; Cordoba A; Pietribiasi F; Kovács A; Faistova H; Cserni G; Quinn C
Eur J Surg Oncol; 2019 Dec; 45(12):2279-2286. PubMed ID: 31301938
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of classic lobular neoplasia diagnosed on breast core needle biopsy: a retrospective multi-center study.
Genco IS; Tugertimur B; Chang Q; Cassell L; Hajiyeva S
Virchows Arch; 2020 Feb; 476(2):209-217. PubMed ID: 31776645
[TBL] [Abstract][Full Text] [Related]
18. Screen-detected pleomorphic lobular carcinoma in situ (PLCIS): risk of concurrent invasive malignancy following a core biopsy diagnosis.
Carder PJ; Shaaban A; Alizadeh Y; Kumarasuwamy V; Liston JC; Sharma N
Histopathology; 2010 Sep; 57(3):472-8. PubMed ID: 20727019
[TBL] [Abstract][Full Text] [Related]
19. Lobular carcinoma in situ variants in breast cores: potential for misdiagnosis, upgrade rates at surgical excision, and practical implications.
Sullivan ME; Khan SA; Sullu Y; Schiller C; Susnik B
Arch Pathol Lab Med; 2010 Jul; 134(7):1024-8. PubMed ID: 20586632
[TBL] [Abstract][Full Text] [Related]
20. Pleomorphic lobular carcinoma in situ (PLCIS) on breast core needle biopsies: clinical significance and immunoprofile.
Chivukula M; Haynik DM; Brufsky A; Carter G; Dabbs DJ
Am J Surg Pathol; 2008 Nov; 32(11):1721-6. PubMed ID: 18769331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
